Storgate LLC Takes $690,000 Position in Corteva, Inc. $CTVA

Storgate LLC acquired a new stake in shares of Corteva, Inc. (NYSE:CTVA) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm acquired 10,299 shares of the company’s stock, valued at approximately $690,000.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. Brighton Jones LLC lifted its stake in Corteva by 307.2% in the 4th quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock worth $888,000 after purchasing an additional 11,760 shares in the last quarter. Woodline Partners LP grew its position in shares of Corteva by 40.3% during the first quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock valued at $3,645,000 after purchasing an additional 16,644 shares in the last quarter. EverSource Wealth Advisors LLC increased its holdings in shares of Corteva by 62.1% in the second quarter. EverSource Wealth Advisors LLC now owns 2,559 shares of the company’s stock worth $191,000 after purchasing an additional 980 shares during the last quarter. Cresset Asset Management LLC increased its holdings in shares of Corteva by 2.6% in the second quarter. Cresset Asset Management LLC now owns 7,063 shares of the company’s stock worth $526,000 after purchasing an additional 181 shares during the last quarter. Finally, Jump Financial LLC bought a new stake in shares of Corteva in the second quarter worth about $1,464,000. 81.54% of the stock is currently owned by institutional investors.

Corteva Stock Performance

Corteva stock opened at $76.14 on Friday. The company’s 50-day moving average price is $80.39 and its 200-day moving average price is $75.31. Corteva, Inc. has a twelve month low of $60.53 and a twelve month high of $85.63. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. The company has a market cap of $50.92 billion, a PE ratio of 44.79, a price-to-earnings-growth ratio of 2.29 and a beta of 0.57.

Corteva (NYSE:CTVA) last posted its earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The firm had revenue of $4.91 billion for the quarter, compared to the consensus estimate of $4.64 billion. During the same period in the previous year, the firm posted $1.13 EPS. The business’s quarterly revenue was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, equities research analysts forecast that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Stockholders of record on Monday, June 1st will be issued a $0.18 dividend. The ex-dividend date is Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s payout ratio is 42.35%.

Analyst Ratings Changes

Several brokerages have recently issued reports on CTVA. Wells Fargo & Company lifted their target price on Corteva from $85.00 to $90.00 and gave the stock an “overweight” rating in a report on Tuesday, April 21st. CICC Research lifted their target price on Corteva from $80.00 to $93.00 and gave the stock an “outperform” rating in a report on Wednesday, May 13th. Barclays lifted their target price on Corteva from $84.00 to $91.00 and gave the stock an “overweight” rating in a report on Thursday. Oppenheimer lifted their target price on Corteva from $86.00 to $89.00 and gave the stock an “outperform” rating in a report on Wednesday, April 22nd. Finally, Citigroup lifted their target price on Corteva from $83.00 to $85.00 and gave the stock a “neutral” rating in a report on Thursday, May 7th. Fourteen research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $88.81.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.